What is IDEX's health & science technologies — cost of sales?

IDEX (IEX) reported health & science technologies — cost of sales of $231.30M in Q1 2026.

How has IDEX's health & science technologies — cost of sales changed year-over-year?

IDEX's health & science technologies — cost of sales increased by 15.0% year-over-year, from $201.20M to $231.30M.

What is the long-term trend for IDEX's health & science technologies — cost of sales?

Over 3 years (2022 to 2025), IDEX's health & science technologies — cost of sales has grown at a 6.2% compound annual growth rate (CAGR), from $738.90M to $885.50M.

What does health & science technologies — cost of sales mean?

The direct costs incurred to produce the goods sold by the Health and Science Technologies segment.

Business Segments · Cost of Sales

Health & Science Technologies — Cost of Sales

IDEX Health & Science Technologies — Cost of Sales decreased by 5.2% to $231.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.0%, from $201.20M to $231.30M. Over 3 years (FY 2022 to FY 2025), Health & Science Technologies — Cost of Sales shows an upward trend with a 6.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementSegment

CategoryEfficiency

SignalLower is better

VolatilityModerate

First reportedQ1 2022

Last reportedQ1 2026Apr 29, 2026

Rolls up toTotal Cost of Revenue

How to read this metric

An increase relative to sales suggests margin compression, while a decrease relative to sales indicates improved manufacturing efficiency.

Detailed definition

Includes the direct costs attributable to the production of goods and services sold within the Health and Science Techno...

Peer comparison

Standard cost of goods sold metric for manufacturing segments across industrial and medical technology companies.

Metric ID: iex_segment_health_science_technologies_cost_of_sales

Historical Data

17 periods

	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$184.73M	$184.73M	$184.73M	$184.73M	$195.78M	$195.78M	$195.78M	$195.78M	$184.30M	$177.60M	$184.10M	$223.50M	$201.20M	$217.00M	$223.30M	$244.00M	$231.30M
QoQ Change	—	+0.0%	+0.0%	+0.0%	+6.0%	+0.0%	+0.0%	+0.0%	-5.9%	-3.6%	+3.7%	+21.4%	-10.0%	+7.9%	+2.9%	+9.3%	-5.2%
YoY Change	—	—	—	—	+6.0%	+6.0%	+6.0%	+6.0%	-5.9%	-9.3%	-6.0%	+14.2%	+9.2%	+22.2%	+21.3%	+9.2%	+15.0%

Range$177.60M – $244.00M

CAGR+5.8%

Avg YoY Growth+7.2%

Median YoY Growth+6.0%

Similar Metrics at Other Companies

International Flavors & FragrancesIFF View metric

Ingersoll RandIR View metric

International Flavors & FragrancesIFF View metric

Ingersoll RandIR View metric

DuPont de Nemours, Inc.DD View metric

Lumentum Holdings Inc.LITE View metric

Frequently Asked Questions

What is IDEX's health & science technologies — cost of sales?: IDEX (IEX) reported health & science technologies — cost of sales of $231.30M in Q1 2026.
How has IDEX's health & science technologies — cost of sales changed year-over-year?: IDEX's health & science technologies — cost of sales increased by 15.0% year-over-year, from $201.20M to $231.30M.
What is the long-term trend for IDEX's health & science technologies — cost of sales?: Over 3 years (2022 to 2025), IDEX's health & science technologies — cost of sales has grown at a 6.2% compound annual growth rate (CAGR), from $738.90M to $885.50M.
What does health & science technologies — cost of sales mean?: The direct costs incurred to produce the goods sold by the Health and Science Technologies segment.